Urology Blogs

Do you own an S corp? Why I made the switchHenry Rosevear, MD, discusses the pros and cons of S corporations and why he decided to create one.
On-Demand and on-target: Why AUA Course Pass is worth your time
On-Demand and on-target: Why AUA Course Pass is worth your timeHenry Rosevear, MD, discusses his experience with the On-Demand Course Pass for this year’s AUA annual meeting, including the two On-Demand courses he found most informative.
Burnout, biopsy, BPH, and more: Post-AUA reviewUrologist Henry Rosevear, MD, reviews his personal highlights from AUA 2017, along with a few bumps in the road.
Millennial urologists display a political awakeningMillennial urologists appear to have developed strong opinions on health policy as reflected by their recent social media activity, observes urologist Alan L. Kaplan, MD.
The ‘post-truth’ world: How it’s drifting into medicineHenry Rosevear, MD, examines how the political notion of a “post-truth” world has seeped into medicine.
Pain control: Let’s rethink our prescribing habitsDr. Henry Rosevear apologizes to those he may have hurt with his prescription habits for pain control and discusses the steps he is taking to help remedy the narcotics epidemic.
Looking ahead to 2017: A urologist’s wish listHenry Rosevear, MD, discusses the ten things he’d like to see happen in 2017 for the field of urology.
Apparently, I'm worth less than a staplerUrologist Henry Rosevear, MD, discusses a recent OR experience that had him rethink his value as a surgeon and consider a possible alternative to better align the financial incentives of the surgeon with the hospital's goals.
Discovering empathy in a place called hellUrology resident, Amy Pearlman, MD, discusses how the experience of helping her mother go through radiation therapy changed how she is able to relate to her patients.
There’s something about PSA: Ben Stiller fights the good fightUrologist Henry Rosevear, MD, discusses actor Ben Stiller's recent blog post that credits PSA tests for saving his life after he was diagnosed with prostate cancer and the urologic community's surprising reaction to the article.